Effect of Peripheral Vestibular Disease Location on Outcomes Following Home-based Virtual Reality Vestibular Therapy
Launched by UNIVERSITY OF BRITISH COLUMBIA · Jun 14, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the location of a problem in the inner ear, known as a vestibular disorder, affects the success of a special virtual reality therapy designed to help patients with balance issues. The researchers want to find out if patients with different types of vestibular disorders, such as Meniere disease or benign paroxysmal positional vertigo, respond differently to this at-home therapy. They will recruit 50 patients who have been diagnosed with these conditions and will randomly assign them to either a group that uses the virtual reality therapy or a control group. After 4 to 8 weeks of treatment, participants will answer questions about their symptoms to see how well the therapy worked.
To take part in this trial, participants need to be at least 18 years old and have been dealing with their vestibular disorder for three months or more. They should have a specific diagnosis confirmed through certain tests. However, pregnant individuals and those with central vestibular disorders (which involve problems in the brain rather than the inner ear) cannot participate. This study will help improve understanding of how different vestibular conditions respond to virtual reality therapy, potentially leading to better treatment options for patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants diagnosed with chronic (≥3 months) unilateral or bilateral peripheral vestibular disorders such as vestibular neuritis, labyrinthitis, Ramsay Hunt syndrome, ischemic lesion and trauma.
- • Diagnosis made using caloric testing (≥25% reduced vestibular response) and either ocular vestibular evoked myogenic potential (oVEMP) or cervical vestibular evoked myogenic potential (cVEMP) testing.
- • Participants prescribed vestibular rehabilitation
- • Participants ≥18 years of age
- • Access to an android or iOS smart phone
- Exclusion Criteria:
- • Pregnant participants
- • Participant diagnosed with a central vestibular disorder
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Patients applied
Trial Officials
Desmond A Nunez, MD, MBA
Principal Investigator
Division of Otolaryngology, Department of Surgery, The University of British Columbia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials